Dipyridamole-Induced Stemi: Case Report and Review of the Literature

Authors

Hussam Al Hennawi, Jefferson Abington HospitalFollow
Sunita Lakhani, Jefferson Abington HospitalFollow
Shayan Iqbal Khan, Jefferson Abington HospitalFollow
Sarin Atam, Jefferson Abington HospitalFollow
Usama Sadiq, Thomas Jefferson University HospitalsFollow
Joseph Rigotti, Jefferson Abington HospitalFollow
Abhinav Nair, Jefferson Abington HospitalFollow

Document Type

Article

Publication Date

6-27-2023

Comments

This article is the author's final published version in Global Cardiology Science & Practice, Volume 2023, Issue 3, Article number 23.

The published version is available at https://doi.org/10.21542/gcsp.2023.23. Copyright © 2023 The Author(s), licensee Magdi Yacoub Institute.

Abstract

Dipyridamole nuclear myocardial perfusion imaging is a safe and useful modality to assess for myocardial ischemia. It is the modality of choice for cardiac risk stratification in patients unable to exercise. Intravenous dipyridamole causes coronary vasodilation and may yield heterogeneity of coronary blood flow in significant coronary artery disease. Ischemic electrocardiographic changes following pharmacologic stress testing are less likely compared to exercise stress tests. Ischemia more likely presents in the form of ST depression, with ST-elevation being exceedingly rare. We present a case of a 73-year-old patient who developed ST-elevation myocardial infarction following pharmacologic stress testing.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Recommended Citation

Al Hennawi, Hussam; Lakhani, Sunita; Khan, Shayan Iqbal; Atam, Sarin; Sadiq, Usama; Rigotti, Joseph; and Nair, Abhinav, "Dipyridamole-Induced Stemi: Case Report and Review of the Literature" (2023). Abington Jefferson Health Papers. Paper 92.
https://jdc.jefferson.edu/abingtonfp/92

Language

English